ModernMedicine Resource Center More Topics

Hot Topics in Prostate Cancer

Prostate Cancer: Studies suggest strategies for marker, mpMRI useFindings from the ProtecT trial, the European Randomized study of Screening for Prostate Cancer, and PIVOT were among the other noteworthy studies in prostate cancer presented at the AUA annual meeting.
MRI-guided PCa detection strategies found cost-effectiveDiagnostic magnetic resonance imaging strategies for the diagnosis of prostate cancer should be considered prior to biopsy of suspicious lesions, according to a recent study.
AUA, ASTRO, SUO release localized PCa guidelineAmong the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.
ASCO issues guidance on second-line hormonal Tx in CRPCThe American Society of Clinical Oncology’s provisional clinical opinion on the use of second-line hormonal therapy for chemotherapy-naïve men with castration-resistant prostate cancer issued by uncovered some surprising findings and issues.
Sleep duration linked to PCa mortality risk in younger menResults of a recent study support a growing body of evidence that factors associated with circadian rhythm disruption might play a role in prostate carcinogenesis.
How to estimate life expectancy in men with localized prostate CaWhile no resource is perfect, it is worthwhile to familiarize yourself with some contemporary methodology and predictive tools to help determine life expectancy in localized prostate cancer patients.
What’s new in updated brachytherapy guidelineThe update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
Studies: PCa treatments differ in QoL outcomesTwo recent JAMA studies confirm a higher rate of sexual and urinary side effects with radical prostatectomy compared with radiation therapy and surveillance.
Single-fraction HDR BT feasible for localized PCaA definitive radiotherapy dose for localized prostate cancer can be safely administered using high-dose rate brachytherapy as a single outpatient procedure.
Mental health conditions contribute to PCa-related costsMood and adjustment disorders were strong predictors of the annual number of outpatient visits, hospital admissions, and number of days in the hospital for patients with prostate and breast cancer, according to a recent study.